Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

BRCA1 and implications for response to chemotherapy in ovarian cancer

(2009) Jennifer E. Quinn et al.   GYNECOLOGIC ONCOLOGY

Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease

(2009) Amir A. Jazaeri   Molecular Oncology

Hereditary ovarian cancer

(2008) Antonio Russo et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

(2008) Noah D. Kauff et al.   JOURNAL OF CLINICAL ONCOLOGY

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

(2008) David S.P. Tan et al.   JOURNAL OF CLINICAL ONCOLOGY

Specialized Care and Survival of Ovarian Cancer Patients in The Netherlands: Nationwide Cohort Study

(2008) F. Vernooij et al.   JNCI-Journal of the National Cancer Institute

Low-grade serous ovarian cancer: a unique disease

(2008) Kathleen M. Schmeler et al.   Current Oncology Reports

Is It Time to Stratify for BRCA Mutation Status in Therapeutic Trials in Ovarian Cancer?

(2007) Noah D. Kauff   JOURNAL OF CLINICAL ONCOLOGY

Effect ofBRCA1/2Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer

(2007) Angela Chetrit et al.   JOURNAL OF CLINICAL ONCOLOGY